252 related articles for article (PubMed ID: 36084314)
1. Drivers of African Filovirus (Ebola and Marburg) Outbreaks.
Stephens PR; Sundaram M; Ferreira S; Gottdenker N; Nipa KF; Schatz AM; Schmidt JP; Drake JM
Vector Borne Zoonotic Dis; 2022 Sep; 22(9):478-490. PubMed ID: 36084314
[TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.
Nyakarahuka L; Schafer IJ; Balinandi S; Mulei S; Tumusiime A; Kyondo J; Knust B; Lutwama J; Rollin P; Nichol S; Shoemaker T
BMC Infect Dis; 2020 Jul; 20(1):461. PubMed ID: 32611400
[TBL] [Abstract][Full Text] [Related]
3. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
4. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
5. Marburg and Ebola virus infections in laboratory non-human primates: a literature review.
Schou S; Hansen AK
Comp Med; 2000 Apr; 50(2):108-23. PubMed ID: 10857001
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
7. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
8. Knowledge and attitude towards Ebola and Marburg virus diseases in Uganda using quantitative and participatory epidemiology techniques.
Nyakarahuka L; Skjerve E; Nabadda D; Sitali DC; Mumba C; Mwiine FN; Lutwama JJ; Balinandi S; Shoemaker T; Kankya C
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005907. PubMed ID: 28892520
[TBL] [Abstract][Full Text] [Related]
9. Geographic potential of disease caused by Ebola and Marburg viruses in Africa.
Peterson AT; Samy AM
Acta Trop; 2016 Oct; 162():114-124. PubMed ID: 27311387
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus.
Wolfe DN; Taylor MJ; Zarrabian AG
Hum Vaccin Immunother; 2020 Nov; 16(11):2855-2860. PubMed ID: 32275465
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
[TBL] [Abstract][Full Text] [Related]
12. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
[TBL] [Abstract][Full Text] [Related]
13. Prospects for immunisation against Marburg and Ebola viruses.
Geisbert TW; Bausch DG; Feldmann H
Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
[TBL] [Abstract][Full Text] [Related]
14. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
[TBL] [Abstract][Full Text] [Related]
15. Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak.
Brett-Major D; Lawler J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30126221
[TBL] [Abstract][Full Text] [Related]
16. Marburg and Ebola viruses as aerosol threats.
Leffel EK; Reed DS
Biosecur Bioterror; 2004; 2(3):186-91. PubMed ID: 15588056
[TBL] [Abstract][Full Text] [Related]
17. Marburg- and Ebolaviruses: A Look Back and Lessons for the Future.
Klenk HD; Slenczka W
Methods Mol Biol; 2017; 1628():3-14. PubMed ID: 28573607
[TBL] [Abstract][Full Text] [Related]
18. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
19. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Filoviridae: Marburg and Ebola viruses.
Beer B; Kurth R; Bukreyev A
Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
